Abstract:Objetives To evaluate the clinical significance of heat shock protein (HSP)-27, HSP-60 and HSP-90 expression in gastric carcinoma. Methods HSP-27, HSP-60 and HSP-90 expression was assessed immunohistochemically in tumoral samples of 66 gastric adenocarcinoma patients and was statistically analyzed in relation to various clinicopathological characteristics, tumor proliferative capacity and patients' survival. Results HSP-27, HSP-60, HSP-90 were abundantly expressed in the gastric adenocarcinoma tissues. HSP-27 expression was significantly associated with tumor size, the presence of organ metastases and pathological stage, while HSP-27 staining intensity was significantly correlated with nodal status. HSP-60 expression was significantly correlated with patients' sex, while HSP-60 staining intensity with patients' age and tumor histopathological grade. HSP-90 expression was not associated with any of the clinicopathological parameters examined; however, HSP-90 staining intensity was significantly associated with tumor size. High HSP-90 expression was significantly associated with longer overall survival time in univariate analysis, and was also identified as an independent prognostic factor in multivariate analysis. Conclusions HSP-27, HSP-60 and HSP-90 are correlated with certain clinicopathological parameters which are crucial for the management of gastric adenocarcinoma patients. HSP-90 expression may also be an independent prognostic indicator in gastric adenocarcinoma patients.